Abstract

The strength of the T cell receptor interaction with self-ligands affects antigen-specific immune responses. However, the precise function and underlying mechanisms are unclear. Here, we demonstrate that naive CD8+ T cells with relatively high self-reactivity are phenotypically heterogeneous owing to varied responses to type I interferon, resulting in three distinct subsets, CD5loLy6C, CD5hiLy6C, and CD5hiLy6C+ cells. CD5hiLy6C+ cells differ from CD5loLy6C and CD5hiLy6C cells in terms of gene expression profiles and functional properties. Moreover, CD5hiLy6C+ cells demonstrate more extensive antigen-specific expansion upon viral infection, with enhanced differentiation into terminal effector cells and reduced memory cell generation. Such features of CD5hiLy6C+ cells are imprinted in a steady-state and type I interferon dependence is observed even for monoclonal CD8+ T cell populations. These findings demonstrate that self-reactivity controls the functional diversity of naive CD8+ T cells by co-opting tonic type I interferon signaling.

There is heterogeneity in the response to self-ligands within the naïve CD8+ T cell pool and the consequences of this are unclear. Here the authors show subsets of naïve CD8+ T cells which differ in expression of Ly6C and CD5 and response to viral infection through regulation by type I IFN signalling.

Details

Title
Self-reactivity controls functional diversity of naive CD8+ T cells by co-opting tonic type I interferon
Author
Young-Jun, Ju 1 ; Sung-Woo, Lee 2 ; Yoon-Chul, Kye 1   VIAFID ORCID Logo  ; Gil-Woo, Lee 2 ; Hee-Ok, Kim 3 ; Cheol-Heui, Yun 1   VIAFID ORCID Logo  ; Jae-Ho, Cho 4   VIAFID ORCID Logo 

 Seoul National University, Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Korea (GRID:grid.49100.3c) (ISNI:0000 0001 0742 4007); Chonnam National University Medical School, Department of Microbiology and Immunology and Medical Research Center for Combinatorial Tumor Immunotherapy, Hwasun, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399); Immunotherapy Innovation Center, Chonnam National University Medical School, Hwasun Hospital, Hwasun, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399) 
 Immunotherapy Innovation Center, Chonnam National University Medical School, Hwasun Hospital, Hwasun, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399) 
 Chonnam National University Medical School, Department of Microbiology and Immunology and Medical Research Center for Combinatorial Tumor Immunotherapy, Hwasun, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399); Immunotherapy Innovation Center, Chonnam National University Medical School, Hwasun Hospital, Hwasun, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399); BioMedical Sciences Graduate Program, Chonnam National University Medical School, Hwasun, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2582904492
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.